1. Pleiotropic and Renoprotective Effects of Erythropoietin Beta on Experimental Diabetic Nephropathy Model
   Zehra Eren et al, 2016, Nephron CrossRef
2. Erythropoietin (EPO) haplotype associated with all-cause mortality in a cohort of Italian patients with Type-2 Diabetes
   Alberto Montesanto et al, 2019, Scientific Reports CrossRef
3. Plant-Produced Asialo-Erythropoietin Restores Pancreatic Beta-Cell Function by Suppressing Mammalian Sterile-20-like Kinase (MST1) and Caspase-3 Activation
   Elena Arthur et al, 2017, Frontiers in Pharmacology CrossRef
4. Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control
   Yun Gao et al, 2022, Stem Cells International CrossRef
5. Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
   Yasunori Iwata et al, 2021, BMC Nephrology CrossRef
6. Erythropoietin accelerates the revascularization of transplanted pancreatic islets
   Maximilian M. Menger et al, 2020, British Journal of Pharmacology CrossRef
7. Non-hematogenic activity of erythropoietin
   Luboslav Stárka et al, 2019, Vnitřní lékařství CrossRef
8. Erythropoietin exposure of isolated pancreatic islets accelerates their revascularization after transplantation
   Maximilian M. Menger et al, 2021, Acta Diabetologica CrossRef
9. Aptamer-based Biosensors: Promising Sensing Technology for Diabetes Diagnosis in Biological Fluids
   Zahra Khoshbin et al, 2023, Current Medicinal Chemistry CrossRef